The LXR agonist TO901317 selectively lowers hippocampal Aβ42 and improves memory in the Tg2576 mouse model of Alzheimer's disease

David Riddell(Eli Lilly (United States)), Jan Jacobsen(Princeton University), Thomas A. Comery(Princeton University), Menelas N. Pangalos(AstraZeneca (United Kingdom)), Warren D. Hirst(Pfizer (United States)), Katie Kubek(Princeton University), Hua Zhou(Dalian Medical University), Cody Lo, Evguenia Kouranova(Princeton University), Robert H. Ring(Autism Speaks), Peter H. Reinhart(University of Massachusetts Amherst), Sarah K. Leonard(Princeton University), Robert Martone(Princeton University), Yolanda Kirksey(Princeton University), Helen K. Warwick(Princeton University), Yi Chen(Chinese Academy of Sciences), Dmytro V. Vasylyev(Princeton University), Suzan Aschmies(Princeton University), Erin Murphy(Princeton University), Catherine Gonzales(Princeton University), Jane Xu(Princeton University), Aram Oganesian(Plex Pharmaceuticals (United States))
Molecular and Cellular Neuroscience
January 26, 2007
Cited by 248


Related Papers